- Nachrichtendetail
-
05.04.2024 15:46:18 - dpa-AFX: *FDA APPROVES BRISTOL MYERS AND 2SEVENTY BIO'S ABECMA FOR TRIPLE-CLASS EXPOSED R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBBDL-10 | 850501 | Frankfurt | 38,950 | 14.06.24 17:08:32 | +0,450 | +1,17% | 0,000 | 0,000 | 38,495 | 38,950 |
